According to Zentalis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$6.45. In 2022 the company made an earnings per share (EPS) of -$6.08 a decrease over its 2021 EPS that were of -$5.08.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$6.54 | 7.45% |
2022 | -$6.08 | 19.84% |
2021 | -$5.08 | 18.48% |
2020 | -$4.28 | 47.26% |
2019 | -$2.91 |